0001203311-18-000087.txt : 20180919
0001203311-18-000087.hdr.sgml : 20180919
20180919183603
ACCESSION NUMBER: 0001203311-18-000087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180917
FILED AS OF DATE: 20180919
DATE AS OF CHANGE: 20180919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIEGALL CLAY B
CENTRAL INDEX KEY: 0001167496
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 181078421
MAIL ADDRESS:
STREET 1: 21823 30TH DR SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-09-17
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001167496
SIEGALL CLAY B
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
1
0
0
President and CEO
Common Stock
2018-09-17
4
M
0
9931
12.16
A
742544
D
Common Stock
2018-09-17
4
S
0
9931
76.36
D
732613
D
Common Stock
2018-09-17
4
M
0
8827
12.16
A
741440
D
Common Stock
2018-09-17
4
S
0
8827
77.2
D
732613
D
Common Stock
2018-09-17
4
M
0
1390
12.16
A
734003
D
Common Stock
2018-09-17
4
S
0
1390
78.0
D
732613
D
Non-Qualified Stock Option (right to buy)
12.16
2018-09-17
4
M
0
9931
0.0
D
2019-08-25
Common Stock
9931
231846
D
Non-Qualified Stock Option (right to buy)
12.16
2018-09-17
4
M
0
8827
0.0
D
2019-08-25
Common Stock
8827
223019
D
Non-Qualified Stock Option (right to buy)
12.16
2018-09-17
4
M
0
1390
0.0
D
2019-08-25
Common Stock
1390
221629
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Reflects sales of common stock executed in multiple transactions at prices ranging from $75.81 to $76.80. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $76.81 to $77.80. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $77.83 to $78.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Shares vested at a rate of 25% on 8/25/10 and monthly thereafter until all the shares were fully vested on 8/25/13.
/s/ Jean Liu
2018-09-19